Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

PHARMAUST LIMITED

INVESTOR PRESENTATION - PHARMAUST LIMITED

ASX:PAA

PHARMAUST LIMITED

Health Care

PharmAust Limited (PAA) is a clinical-stage company developing targeted cancer therapeutics to address both human and animal healthcare. The company specialises in repurposing marketed drugs lowering the risks and costs of development. These efforts are supported by PAA’s subsidiary, Epichem, which is a highly successful contract medicinal chemistry company that generates significant annual revenues.

Read more

Market Cap

$36.37m

Price at Close

$0.115

4w avg. Volume

616.41k

4w avg. Turnover

$68.85k

Announcements
announcementt+2 movementdate
  • Results of Annual General Meeting

    Notice Of Meeting

  • +4.55%

    05 Nov 2020

+4.55%

05 Nov 2020
  • AGM Shareholder Presentation

    Periodic Reports

  • +4.55%

    05 Nov 2020

+4.55%

05 Nov 2020
  • Appendix 4C and Quarterly Update

    Commitments test entity quarterly reports · Market sensitive

  • -8.00%

    28 Oct 2020

-8.00%

28 Oct 2020
  • Appendix 2A & s708 notice (exercise of employee options)

    Issued Capital

  • -3.70%

    20 Oct 2020

-3.70%

20 Oct 2020
  • Appendix 3G

    Issued Capital

  • -3.70%

    20 Oct 2020

-3.70%

20 Oct 2020
  • Appendix 2A & s708 notice

    Issued Capital

  • 0.00%

    12 Oct 2020

0.00%

12 Oct 2020
  • Notice of Annual General Meeting/Proxy Form

    Notice Of Meeting

  • -4.00%

    02 Oct 2020

-4.00%

02 Oct 2020
  • ONJCRI Evaluates Monepantel Anti-Cancer Mechanism

    Progress Report · Market sensitive

  • +4.00%

    28 Sep 2020

+4.00%

28 Sep 2020
  • Clarification statement

    Progress Report

  • +4.00%

    28 Sep 2020

+4.00%

28 Sep 2020
  • PAA Evaluate MPL Suitability for Ex-Vivo Human COVID-19 Test

    Progress Report · Market sensitive

  • +4.00%

    23 Sep 2020

+4.00%

23 Sep 2020
Market Data

Current Price

$0.115

52WK HIGH

$0.275

52WK LOW

$0.057

1YR RETURN

+9.52%

1YR RETURN VS. SECTOR

-1820.55%

90 DAY RETURN

-37.84%

ASX RANK

1,233

/2,026

SECTOR RANK

22

/32

SHARES OUTSTANDING

316.23m
ASX:PAA

PHARMAUST LIMITED

Health Care

PharmAust Limited (PAA) is a clinical-stage company developing targeted cancer therapeutics to address both human and animal healthcare. The company specialises in repurposing marketed drugs lowering the risks and costs of development. These efforts are supported by PAA’s subsidiary, Epichem, which is a highly successful contract medicinal chemistry company that generates significant annual revenues.

Read more

Market Cap

$36.37m

Price at Close

$0.115

4w avg. Volume

616.41k

4w avg. Turnover

$68.85k

ASX:PAA is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.